AZEFLU®
Reg. San. No. INVIMA: INVIMA 2018M-0018440.
PRINCIPIO ACTIVO: Azelastina clorhidrato, Fluticasona propionato.
UNIDAD DE VENTA: Frasco PEAD con 30 mL, con bomba atomizadora nasal AP.
Referencias
- Bousquet J, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*: ARIA: 2008 Update. Allergy 2008.
- Canonica GW, Mullol J, Pradalier A, Didier A. Patient Perceptions of Allergic Rhinitis and Quality of Life. World Allergy Organization Journal 2008.
- Dennis RJ, et al. Prevalence of asthma and other allergic conditions in Colombia 2009–2010: a cross-sectional study. BMC Pulm Med 2012.
- Brożek JL, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision. Journal of Allergy and Clinical Immunology [Internet] 2017.
- Hellings PW, et al. Explorative study on patient’s perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis. Clinical and Translational Allergy 2012.
- Bousquet J, et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. Journal of Allergy and Clinical Immunology 2016.
- Tan R, et al. Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon. asthma res and pract 2017.
- Wahid NWB, Shermetaro C. Rhinitis Medicamentosa. En: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.
- Bousquet J, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. Journal of Allergy and Clinical Immunology 2020.
- Meltzer EO, et al. Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity. allergy asthma proc 2020.
- Klimek L, et al. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review. Int Arch Allergy Immunol 2021.
- Carr W, et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. Journal of Allergy and Clinical Immunology 2012.
- Price D, et al. A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis. J Investig Allergol Clin Immunol 2013.
- Williams DC, Edney G, Maiden B, Smith PK. Recognition of allergic conjunctivitis in patients with allergic rhinitis. World Allergy Organization Journal 2013.
- Seresirikachorn K, et al. Effects of H1 antihistamine addition to intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis: Antihistamine and intranasal steroid. Int Forum Allergy Rhinol 2018.
- Hampel FC, et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Annals of Allergy, Asthma & Immunology 2010.
- Bachert C, Bousquet J, Hellings P. Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management. Clin Transl Allergy 2018.
- Bousquet J, et al. Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber. The Journal of Allergy and Clinical Immunology: In Practice 2018.
- Caballer B de la H, et al. Allergic Rhinitis and Its Impact on Work Productivity in Primary Care Practice and a Comparison with Other Common Diseases: The Cross-sectional Study to Evaluate Work Productivity in Allergic Rhinitis Compared with Other Common Diseases (CAPRI) Study. Am J Rhinol�Allergy 2012.
- Meltzer EO, et al. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial of efficacy and safety. allergy asthma proc 2012;33(4):324-32.
- Klimek L, et al. MP-AzeFlu provides rapid and effective allergic rhinitis control in real life: A pan-European study. allergy asthma proc 2016.
- Berger W, et al. MP ‐AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children. Allergy 2016.
- Berger W, et al. Efficacy of MP ‐AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment. Pediatr Allergy Immunol 2016.
- Berger W, et al. Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial. allergy asthma proc 2018.